A3 Adenosine Receptor Activation in Melanoma Cells

This publication has 27 references indexed in Scilit:

• Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells
  Oncogene, 2002
• The A3 Adenosine Receptor as a New Target for Cancer Therapy and Chemoprotection
  Experimental Cell Research, 2001
• Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
  Proceedings of the National Academy of Sciences, 2000
• Nuclear β-catenin displays GSK-3β- and APC-independent proteasome sensitivity in melanoma cells
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
• Adenosine receptors: new opportunities for future drugs
  Published by Elsevier ,2000
• The role of receptor structure in determining adenosine receptor activity
  Pharmacology & Therapeutics, 2000
• Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor
  Journal of Cellular Physiology, 2000
• β-catenin signaling and cancer
  BioEssays, 1999
• A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
  The Journal of Experimental Medicine, 1996
• Two distinct subpopulations of endosomes involved in membrane recycling and transport to lysosomes
  Cell, 1988